Table 2. Treatment incidences (min-max) based on the animal unit dose (UD; TI_UD) and prescribed daily dose (UDD; TI_UDD) of the topical antimicrobial drugs in the different herd types.

Active substance	ATCveta	Indication	UD (mg)	Dairy herds		Beef herds
Intramammary drugs				TIUD	TIUDD	TIUD	TIUDD
Procaine penicillin+ neomycin	QJ51RC	Md	500	0.07	0.03	-	-
				(0.00–0.43)	(0.00–0.22)
Cloxacillin	QJ51CF	M	100	0.23	0.06	-	-
				(0.00–1.14)	(0.00–0.31)
Cloxacillin	QJ51CF	De	2200	0.55	0.55	-	-
				(0.00–1.11)	(0.00–1.11)
Nafcillin+benzylpenicillin+DHSb	NAc	M	100	0.59	0.45	0.06	0.06g
				(0.00–1.42)	(0.00–1.21)	(0.00–0.49)	(0.00–0.49)
Nafcillin+benzylpenicillin+DHS	NA	D	400	0.24	0.24	-	-
				(0.00–1.22)	(0.00–1.22)
Cefquinome	QJ51DA	M	150	0.43	0.60	-	-
				(0.00–1.02)	(0.00–0.97)
Cefalexin	QJ51DA	M	400	0.35	0.39	-	-
				(0.00–2.05)	(0.00–2.31)
Lincomycin+neomycin	QJ51RF	M	660	0.17	0.29	0.03	0.03g
				(0.00–0.43)	(0.00–0.71)	(0.00–0.30)	(0.00–0.30)
Pirlimycin	QJ51FF	M	50	0.21	0.10	-	-
				(0.00–1.03)	(0.00–0.51)
Total				2.83	2.71	0.09	0.09
				(1.81–3.70)	(0.94–3.83)	(0.00–0.79)	(0.00–0.79)
Intra-uterine drugs
Cefapirin	QG01DA	Vf	500	0.17	0.16	<0.01	<0.01
				(0.00–0.78)	(0.00–0.77)	(0.0–0.02)	(0.0–0.02)
Chlortetracycline hydrochloride	QG01AA	V	1500	0.25	0.16	0.78	1.07
				(0.00–0.52)	(0.00–0.34)	(0.36–1.08)	(0.39–1.62)
Total				0.42	0.32	0.78	1.07
				(0.00–1.27)	(0.00–1.11)	(0.38–1.08)	(0.39–1.62)
Grand total topical use				3.25	3.03	0.87	1.16

^aAnatomical Therapeutic Chemical classification system for Veterinary medicinal products

^bdihydrostreptomycin

^cnot available

^dM: mastitis

^eD: dry cow therapy

^fV: variable (prophylactic and/or therapeutic)

^g TI_UD values were used to calculate the total TI_UDD